Anzeige
Mehr »
Login
Freitag, 27.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D1EU | ISIN: BE6333353298 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BONYF NV Chart 1 Jahr
5-Tage-Chart
BONYF NV 5-Tage-Chart

Aktuelle News zur BONYF Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.12.bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market241DJ bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market bonyf NV / Key word(s): Alliance/Investment bonyf and Honest Pharma...
► Artikel lesen
09.12.bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions265DJ bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions bonyf NV / Key word(s): Regulatory Admission/Regulatory Approval bonyf Achieves MDR Certification...
► Artikel lesen
28.11.bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India270DJ bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India bonyf NV / Key word(s):...
► Artikel lesen
BONYF Aktie jetzt für 0€ handeln
24.10.bonyf NV: PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care534DJ PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care bonyf NV / Key word(s): Product Launch/Research Update PerioTabs Innovative 10-Day NitrAdine-Based Treatment...
► Artikel lesen
03.09.bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks655DJ bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks bonyf NV / Key word(s): Study/Study results bonyf's Advanced Skincare Formula Offers Fast Relief for Heel...
► Artikel lesen
18.07.bonyf NV: Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives577DJ Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives bonyf NV / Key word(s): Research Update/Scientific publication Olivafix® Gold: Showcasing Our Pioneering R&D in Denture...
► Artikel lesen
28.06.bonyf NV: bonyf's 2023 financial statements made available410DJ bonyf NV: bonyf's 2023 financial statements made available bonyf NV / Key word(s): Annual Results bonyf NV: bonyf's 2023 financial statements made available 28-Jun-2024 / 17:12 CET/CEST...
► Artikel lesen
07.06.bonyf NV: Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream564DJ Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream bonyf NV / Key word(s): Research Update/Scientific publication Advanced R&D capabilities and...
► Artikel lesen
16.04.bonyf exhibits at PLMA Amsterdam on 28-29 May 2024376DJ bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 bonyf NV / Key word(s): Development of Sales/Investment bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 16-Apr-2024 / 15:19 CET/CEST =----------------------------------------------------------------------------------------------------------------------...
► Artikel lesen
04.04.bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream365DJ bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream bonyf NV / Key word(s): Research Update/Product Launch bonyf Advances to Phase 2 in Development of Alginate-Organic...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1